Resistant Hypertension Effectively Treated With Novel Drug.
1. 文件大小不能超过300M, 允许上传文档或压缩包等
2. 请确保上传文献的真实性、完整性，不得对原文做任何修改
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接:
其他信息:
N Persaud
Medical Bag, 2022
go.gale.com
Aprocitentan, a dual endothelin receptor A and B antagonist, shows modest efficacy in treating resistant hypertension, but is associated with increased risks for edema and fluid retention, according to new study findings.In part 1 of the PRECISION study, investigators randomly assigned 730 patients to receive aprocitentan 12.5 mg, aprocitentan 25 mg, or placebo for 4 weeks. In part 2, all patients received aprocitentan 25 mg for 32 weeks. In part 3, the withdrawal phase, investigators randomly assigned patients to receive aprocitentan …
